Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-03-26 @ 3:17 PM
NCT ID:
NCT07311135
Eligibility Criteria:
Inclusion Criteria:
* Aged 18-years old and above.
* Diagnosed with pulmonary hypertension by right heart catheterisation showing a baseline mean pulmonary artery pressure \> 20mmHg, PVR \>2 Woods Units.
* Able to perform a six-minute walk test (6MWT)
* Able to give written informed consent.
Exclusion Criteria:
* Peripheral arterial disease
* Tattoos or skin markings which cover the dorsal wrist.
* Resting SpO2 \<88%
* Severe concurrent medical condition that would prevent participation in study procedures or with life expectancy \<3 months
* Patients with bleeding disorders
* Patients on anticoagulation
* Except in circumstances where anticoagulation is given solely for historical perceived long term survival benefit for pulmonary arterial hypertension. This patient group could be given the option to come off their anticoagulation for 1 week prior to the study visit if they wished to take part in the study. It could then be restarted the day following the study visit providing there were no bleeding complications related to the arterial line.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07311135
Study Brief:
Protocol Section:
NCT07311135